CASEY HATFIELD: Open Payments
NPI 1710456561 · MADISON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,267 in 68 payments from 12 companies in 2025. Trend: 2023 $289 · 2024 $943 · 2025 $1,267
Food & beverage: $1,267
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $222 |
| Otsuka America Pharmaceutical, Inc. | 9 | $221 |
| ABBVIE INC. | 9 | $154 |
| Alkermes, Inc. | 10 | $135 |
| Lundbeck LLC | 5 | $118 |
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| Teva Pharmaceuticals USA, Inc. | 5 | $96 |
| Janssen Pharmaceuticals, Inc | 3 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
Products named: REXULTI, CAPLYTA, VRAYLAR, COBENFY, ARISTADA, AUSTEDO XR, FANAPT, SPRAVATO.
Industry payments across WV — which companies pay providers there.
